Research Article

Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA

Table 1

Top 5 MCODE pathway and process enrichment analysis for each group.

MCODEGODescriptionLog10 ()

MCODE 1R-HSA-195258RHO GTPase effectors−12.0
MCODE 1R-HSA-9664422FCGR3A-mediated phagocytosis−10.4
MCODE 1R-HSA-9664417Leishmania phagocytosis−10.4
MCODE 2R-HSA-72163mRNA splicing—major pathway−11.4
MCODE 2R-HSA-72172mRNA splicing−11.3
MCODE 2R-HSA-72203Processing of capped intron-containing pre-mRNA−10.4
MCODE 3GO:0040029Regulation of gene expression, epigenetic−6.1
MCODE 3GO:0051052Regulation of the DNA metabolic process−6.0
MCODE 3GO:0034728Nucleosome organization−5.8
MCODE 4R-HSA-909733Interferon alpha/beta-signalling−37.1
MCODE 4R-HSA-913531Interferon signalling−30.3
MCODE 4R-HSA-1280215Cytokine signalling in the immune system−22.4
MCODE 5R-HSA-5696395Formation of incision complex in GG-NER−10.9
MCODE 5R-HSA-5696399Global genome nucleotide excision repair (GG-NER)−9.4
MCODE 5R-HSA-5696398Nucleotide excision repair−8.8